Skip to search formSkip to main contentSkip to account menu

PC-3 cell line

Known as: PC-3 
An adenocarcinoma cell line established in 1979 from a bone metastasis from a 62 year old Caucasian male patient with stage IV prostate carcinoma.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
PurposeCholine derivatives labelled with positron emitters are successfully used for PET imaging of prostate cancer patients… 
Highly Cited
2009
Highly Cited
2009
Synthetic triterpenoids are potent anticancer agents, but their therapeutic efficacy or mechanism of action for prostate cancer… 
Highly Cited
2008
Highly Cited
2008
Thromboxane A(2) (TxA(2)) is a prostanoid formed by thromboxane synthase using the cyclooxygenase product prostaglandin H(2) as… 
Highly Cited
2007
Highly Cited
2007
P276-00, a flavone that inhibits cyclin-dependent kinases, has been identified by us recently as a novel antineoplastic agent. In… 
Highly Cited
2004
Highly Cited
2004
RRR-α-tocopheryl succinate (α-vitamin E succinate, VES), one of the vitamin E derivatives, can effectively inhibit the… 
Highly Cited
2001
Highly Cited
2001
Although ion channels are known to contribute to a variety of basic cellular behaviors involved in the metastatic cascade, their… 
Highly Cited
1996
Highly Cited
1996
Bombesin and gastrin-releasing peptide (GRP) are potent neuropeptides expressed by prostate cancer neuroendocrine cells and are… 
Highly Cited
1991
Highly Cited
1991
We have investigated the role of urokinase (UK) and its cell-surface receptor in determining the invasiveness of prostate cancer…